• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. URETERO-RENO FIBERSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. URETERO-RENO FIBERSCOPE Back to Search Results
Model Number URF-P6
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Urethral Stenosis/Stricture (4501); Unspecified Kidney or Urinary Problem (4503)
Event Date 09/21/2021
Event Type  Injury  
Event Description
Olympus reviewed the following literature titled "the impact of preoperative percutaneous nephrostomy as a treatment strategy before flexible ureteroscopy for impacted upper ureteral stones with hydronephrosis".Literature summary: the current study aimed to evaluate the impact of preoperative percutaneous nephrostomy (pns) as a treatment strategy before flexible ureteroscopy (f-urs) of asymptomatic impacted upper ureteral stones with hydronephrosis.There were no significant differences in age, sex, and stone size between the two groups except in the grade of hydronephrosis, with group a having more cases of advanced hydronephrosis than group b.The stone-free rate was significantly higher in group a than in group b.However, there were no significant differences between the groups in operation time, postoperative fever, and postoperative hospital days.In group a, preoperative pns placement was performed 4 days before f-urs, and the pns was removed postoperatively on the same day of the f-urs.Additionally, subgroup analysis was performed in cases of grade 2 and 3 hydronephrosis.A total of 110 patients, 60 who underwent f-urs with pns and 50 who underwent f-urs without pns, were included.The stone-free rate was significantly higher in f-urs with pns than in f-urs without pns.However, no significant differences were found between the groups in operation time, ureteral injury, postoperative fever, and postoperative hospital days.Type of adverse events/number of patients: urs with pns (n=61): uretral injury - 3 patients, fever - 3 patients, postoperative hydronephrosis -10 patients.Urs without pns (n=75): uretral injury - 8 patients, fever - 4 patients, postoperative hydronephrosis - 12 patients, ureteral stenosis - 2 patients.This complaint is (b)(6).
 
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
URETERO-RENO FIBERSCOPE
Type of Device
URETERO-RENO FIBERSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer Contact
masaharu hirose
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8-520
JA   965-8520
426422891
MDR Report Key15117633
MDR Text Key296759641
Report Number9610595-2022-00362
Device Sequence Number1
Product Code FGB
UDI-Device Identifier04953170340802
UDI-Public04953170340802
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K172298
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberURF-P6
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/27/2022
Initial Date FDA Received07/27/2022
Supplement Dates Manufacturer Received09/05/2022
Supplement Dates FDA Received09/21/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-